3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Melanoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Exostoses, Multiple Hereditary
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Breast Cancer Lymphedema
1
BTC
1
Interventions
Biopsy
5
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
larotrectinib
2
erdafitinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
ulixertinib
1
tipifarnib
1
tazemetostat
1
selpercatinib
1
palbociclib
1
olaparib
1
niraparib
1
ivosidenib
1
elacestrant
1
alectinib
1
abemaciclib
1
Vincristine
1
Vinblastine
1
Vemurafenib
1
Temozolomide
1
RAD1901
1
Paclitaxel
1
Methotrexate
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Surgical Procedures, Operative
×
30 days
×
Clear all
No trials found.